Fundraising in AI: Life Sciences & Tech Investor Panel
AI is transforming how we discover drugs, deliver healthcare, and power next-generation technologies. From predictive algorithms that accelerate clinical trials to AI-driven biotech platforms reshaping R&D, the opportunity for innovation — and investment — has never been greater.
Join a distinguished panel of family offices, seasoned angel investors, and experienced VCs for an in-depth conversation on where the smartest capital is flowing in AI for life sciences and technology. This event will feature a dynamic panel discussion, audience Q&A, and opportunities to network with fellow entrepreneurs, scientists, and investors who are shaping the future.
Featured Speakers:
Gary Fowler, President of Fowler Family Office and CEO of GSD Venture Studios
Stuart Hart, MD, MBA, MS, Venture Partner at VU and CEO, Urology Health.
Sammy Datwani, Ph.D., Board Member of Life Science Angels
Paul M. Russo, Ph.D., Founder & CEO of K2X Technology & Life Science
Presented in partnership with Perkins Coie, DECODE and Berkeley Venture Capital.
Who Should Attend:
Life science and biotech founders
AI and tech entrepreneurs
Venture capitalists and angel investors
Researchers and academics
Professionals curious about AI’s impact on healthcare and tech innovation
Event Schedule
5:30 – 5:50 PM | Arrival & Networking
Check in, enjoy light refreshments, and connect with attendees before the program begins.
5:50 – 6:00 PM | Welcome Remarks
Host introduction and event framing.
6:00 – 6:45 PM | Investor Panel: Funding the Future of AI in Life Sciences & Tech
A moderated discussion with top investors on market trends, funding strategies, and opportunities in AI innovation.
6:45 – 7:10 PM | Audience Q&A
Attendees ask direct questions to the panelists.
7:10 – 7:30 PM | Networking & Closing
Final opportunity to meet speakers and exchange contacts.